Shares of Elite Pharmaceuticals, Inc. ELTP have lost 3.3% since the company reported its earnings for the quarter ended Dec. 31, 2024. This compares to the S&P 500 Index’s 1.2% gain over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback